Hypothyroidism Market By Key Manufacturers, By Treatment (Levothyroxine Sodium, Liothyronine and Others), By Route of Administration (Oral, Intravenous and Others), By End User (Hospitals & Clinics, Academic & Research Institutes and Others) and By Regions (North America, Europe, Middle East and Africa, Latin America and Asia Pacific) - Global Outlook to 2026
Report ID: 178131 | Jun 2019 | No. of Pages: 120 |
Global Hypothyroidism Market is valued USD 1.48 Billion in 2018 and is projected is to exhibit 3.5% CAGR during the forecast period. The market is projected to be around USD 2.13 billion by 2026. The market is driven by the increasing number of thyroid gland disease patients across the globe.

Hypothyroidism (underactive thyroid) is a condition that results is in improper functioning of thyroid gland which there by results in lower levels of crucial hormone production. Hypothyroidism may not cause noticeable symptoms in its early stages. However, if not treated, hypothyroidism can cause a number of health problems, such as obesity, infertility, joint pains, and heart diseases.
Hypothyroidism Market Dynamics
Growing prevalence of thyroid gland disease, rise in number obese & diabetic patients, increasing awareness on prevention & treatment for hypothyroidism, and growing R&D investment by key pharmaceutical companies to develop novel drugs can be the key factors attributing to the growth of Hypothyroidism Market in the coming years. However, increasing usage of alternate medicines is expected to restraint the market growth to a certain extent in the coming years.

Changing lifestyles & habits in emerging nations and incessant approvals by regulatory bodies for commercial availability of hypothyroidism treatment are expected to offer significant growth opportunities in the coming years.
Hypothyroidism Market Insight
North America holds the major market share of the global Hypothyroidism Market due to increasing number of thyroid disorders in the country. According to the American Thyroid Association, over 12% of the US population is estimated to suffer from thyroid disorders during their life time. Furthermore increasing number of FDA approvals are expected to bolster the growth of US market.
Hypothyroidism Market Segmentation
The global Hypothyroidism Market is segmented into treatment, route of administration, end user, and region. On the basis of the treatment the market is further bifurcated into Levothyroxine Sodium, Liothyronine, and others. The market based on route of administration is segmented into oral, intravenous and other. On the basis of end user, the market is categorized as, hospitals & clinics and academic & research institutes, and others. Based on the geography the market is further segregated into North America, Latin America, Middle East & Africa, Europe and Asia Pacific.
Hypothyroidism Market Competitive Landscape
The players associated with the global Hypothyroidism Market include Pfizer, Inc., Merck & Co., Inc., Novartis AG, GlaxoSmithKline, Erfa Canada, Mylan N.V., Allergan, AbbVie, Inc., and RLC labs, among others.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
Chapter 4. Market Outlook
4.1. Market Dynamics
4.1.1. Market Drivers
4.1.2. Market Restraints
4.1.3. Market Opportunities
4.2. Porter’s Analysis
4.3. Value Chain Analysis
Chapter 5. Hypothyroidism Market, By Treatment
5.1. Hypothyroidism Market, by Treatment, 2018-2026
5.2. Levothyroxine Sodium
5.3 Liothyronine
5.4 Others
Chapter 6. Hypothyroidism Market, By Route of Administration
6.1. Hypothyroidism Market, by Route of Administration, 2018-2026
6.2.Oral
6.3 Intravenous
6.4 Others
Chapter 7. Hypothyroidism Market, By End User
7.1. Hypothyroidism Market, by End User, 2018-2026
7.2.Hospitals & Clinics
7.3 Academic & Research Institutes
7.4 Others
Chapter 8. Hypothyroidism Market, By Regions
8.1. Hypothyroidism Market, by Region, 2018-2026
8.1.1. North America
8.1.1.1. U.S
8.1.1.2. Rest of North America
8.1.2. Europe
8.1.2.1. U.K.
8.1.2.2. Germany
8.1.2.3. France
8.1.2.4. Rest of the Europe
8.1.3. Middle East & Africa (MEA)
8.1.3.1. GCC
8.1.3.2. North Africa
8.1.3.3. South Africa
8.1.3.4. Rest of MEA
8.1.4. Latin America (LATAM)
8.1.4.1. Brazil
8.1.4.2. Rest of LATAM
8.1.5. Asia Pacific (APAC)
8.1.5.1. India
8.1.5.2. China
8.1.5.3. Japan
8.1.5.4. Rest of the APAC
Chapter 9. Competitive Landscape
9.1.1. Key Strategies Adopted by Players
9.1.2. Market Share/Positioning Analysis
Chapter 10. Company Profiles
10.1. Pfizer, Inc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Mylan NV
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Merck & Co., Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Novartis AG
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. AbbVie, Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Allergan
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. RLC Labs
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Erfa Canada Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. GlaxoSmithKline
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
Pfizer Inc.
Merck & Co. Inc.
Novartis AG
GlaxoSmithKline
Erfa Canada
Mylan N.V.
Allergan
AbbVie Inc.
RLC labs

1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
3. Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
4. It provides a forward looking perspective on different factors driving or restraining market growth
5. It provides a eight-year forecast assessed on the basis of how the market is expected to grow
6. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segment

Select License Type
USD $4250
USD $6250
Connect With Us

+1-707-633-0404


Global Bone Substitutes Market Status and Future Forecast Report 2016-2026
Publication Month: Sep 2019 | No. of Pages: 50
$1800
Buy Now
Global Bone Staple Market Status and Future Forecast Report 2016-2026
Publication Month: Sep 2019 | No. of Pages: 51
$1800
Buy Now
Global Bone Punches Market Status and Future Forecast Report 2016-2026
Publication Month: Sep 2019 | No. of Pages: 53
$1800
Buy Now
Global Bone Mineral Testing Market Status and Future Forecast Report 2016-2026
Publication Month: Sep 2019 | No. of Pages: 65
$1800
Buy Now
Global Bone Metabolism Tests Market Status and Future Forecast Report 2016-2026
Publication Month: Sep 2019 | No. of Pages: 51
$1800
Buy Now